Back to search

Switzerland· 66580002

Lutathera CA 370 MBq/ml, Infusionslösung

A lutetium (177lu) oxodotreotide product containing lutetium(177-lu(ca)) oxodotreotidum, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A. The same ATC class is registered in 11 of our 19 countries.

Cat A (Swissmedic)ATC V10XX04

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedLutathera CA 370 MBq/ml, Infusionslös…ATCV10XX04REGISTER NO.66580002PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Lutetium (177lu) oxodotreotide is registered in 11 of 19 countries.

Countries holding a registration under ATC V10XX04 (lutetium (177lu) oxodotreotide), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Lutetium (177lu) oxodotreotide · ATC V10XX04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
lutetium(177-Lu(CA)) oxodotreotidum
Manufacturer
Novartis Pharma Schweiz AG
Country
Switzerland (CH)
ATC code
V10XX04
ATC class
Lutetium (177Lu) oxodotreotide
Swissmedic category
A
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4f5772dc-9656-4dfa-a8a7-5600eddfbd87
GET /v1/drugs/4f5772dc-9656-4dfa-a8a7-5600eddfbd87?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about lutetium (177lu) oxodotreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.